These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26638268)

  • 21. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
    Tapson VF; Decousus H; Pini M; Chong BH; Froehlich JB; Monreal M; Spyropoulos AC; Merli GJ; Zotz RB; Bergmann JF; Pavanello R; Turpie AG; Nakamura M; Piovella F; Kakkar AK; Spencer FA; Fitzgerald G; Anderson FA;
    Chest; 2007 Sep; 132(3):936-45. PubMed ID: 17573514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of venous thrombosis in medical patients: A real-world perspective.
    Richards GA; Schoeman HS
    Cardiovasc J S Afr; 2006; 17(5):251-4. PubMed ID: 17117230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Merli GJ
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism risk and prophylaxis in the acute hospital care setting--results of the ENDORSE study in Poland.
    Musiał J; Sydor WJ;
    Pol Arch Med Wewn; 2008 Oct; 118(10):555-61. PubMed ID: 19112816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study.
    Cohen AT; Harrington R; Goldhaber SZ; Hull R; Gibson CM; Hernandez AF; Kitt MM; Lorenz TJ
    Am Heart J; 2014 Mar; 167(3):335-41. PubMed ID: 24576517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
    Hillis C; Crowther MA
    Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of deep-vein thrombosis prophylaxis in the nonsurgical patient: The MEDENOX trial.
    Cohen AT; Zaw HM; Alikhan R
    Semin Hematol; 2001 Apr; 38(2 Suppl 5):31-8. PubMed ID: 11449341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients.
    Le Sage S; McGee M; Emed JD
    J Vasc Nurs; 2008 Dec; 26(4):109-17. PubMed ID: 19022169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system.
    Dorfman M; Chan SB; Maslowski C
    J Clin Pharm Ther; 2006 Oct; 31(5):455-9. PubMed ID: 16958823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving the use of anticoagulant therapies in acutely ill medical patients.
    Dobesh PP; Phillips KW; Haines ST
    Am J Health Syst Pharm; 2008 Aug; 65(15 Suppl 7):S5-12. PubMed ID: 18653824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvement.
    Stevens SM; Douketis JD
    Clin Chest Med; 2010 Dec; 31(4):675-89. PubMed ID: 21047575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprophylaxis for venous thromboembolism in otolaryngology.
    Bahl V; Shuman AG; Hu HM; Jackson CR; Pannucci CJ; Alaniz C; Chepeha DB; Bradford CR
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):999-1005. PubMed ID: 25275427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G; Subedi P
    Am J Manag Care; 2002 Dec; 8(12):1082-8. PubMed ID: 12500884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.
    Dobesh P
    Int J Clin Pract; 2010 Oct; 64(11):1554-1562. PubMed ID: 20846203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and economic outcomes with appropriate or partial prophylaxis.
    Amin AN; Lin J; Johnson BH; Schulman KL
    Thromb Res; 2010 Jun; 125(6):513-7. PubMed ID: 19931121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.